W A O'BRIEN - JoVE Visualize

Showing results (21-30 of 37) with videos related to

Pageof 4

Sort By:

Nature|November 1, 1990

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domainW A O'Brien, Y Koyanagi, A Namazie, et al.

Transfusion|October 1, 1996

Human immunodeficiency virus type 1 activation after blood transfusionP M Mudido, D Georges, D Dorazio, et al.

Vaccine|July 31, 1998

Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trialS A Tasker, W A O'Brien, J J Treanor, et al.

Journal of Virology|August 17, 2001

Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptorC A Derdeyn, J M Decker, J N Sfakianos, et al.

Journal of Virology|October 10, 1998

Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivorK Grovit-Ferbas, J Ferbas, V Gudeman, et al.

The New England Journal of Medicine|February 15, 1996

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDSW A O'Brien, P M Hartigan, D Martin, et al.

AIDS (London, England)|June 10, 1998

Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 yearsA Arnó, L Ruiz, M Juan, et al.

AIDS (London, England)|August 17, 1999

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapyF García, M Plana, C Vidal, et al.

The Journal of Experimental Medicine|October 23, 1997

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptorB J Doranz, K Grovit-Ferbas, M P Sharron, et al.

Journal of Virology|December 16, 1998

Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditionsY Suzuki, Y Koyanagi, Y Tanaka, et al.

Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:

Pageof 4

Nature|November 1, 1990

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domainW A O'Brien, Y Koyanagi, A Namazie, et al.

Transfusion|October 1, 1996

Human immunodeficiency virus type 1 activation after blood transfusionP M Mudido, D Georges, D Dorazio, et al.

Vaccine|July 31, 1998

Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trialS A Tasker, W A O'Brien, J J Treanor, et al.

Journal of Virology|August 17, 2001

Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptorC A Derdeyn, J M Decker, J N Sfakianos, et al.

Journal of Virology|October 10, 1998

Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivorK Grovit-Ferbas, J Ferbas, V Gudeman, et al.

The New England Journal of Medicine|February 15, 1996

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDSW A O'Brien, P M Hartigan, D Martin, et al.

AIDS (London, England)|June 10, 1998

Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 yearsA Arnó, L Ruiz, M Juan, et al.

AIDS (London, England)|August 17, 1999

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapyF García, M Plana, C Vidal, et al.

The Journal of Experimental Medicine|October 23, 1997

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptorB J Doranz, K Grovit-Ferbas, M P Sharron, et al.

Journal of Virology|December 16, 1998

Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditionsY Suzuki, Y Koyanagi, Y Tanaka, et al.

Pageof 4